Thrombin Generation Assays: What are the Current Clinical Applications?
Authors:
- 7 April 2025
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 52 (04) , 441-447
Abstract
The thrombin generation assay (TGA), originally developed by McFarlane and Biggs in 1956, was modified in the 2000s by Hemker and coworkers. TGA aims to monitor the continuous generation of thrombin upon activation of coagulation in plasma by the addition of such triggers as small amounts of tissue factor, synthetic phospholipids, and calcium chloride. TGA is sensitive to hypo- and hypercoagulability and is affected by prohemostatic as well as antithrombotic drugs. The review of the current literature shows that TGA is mainly used to investigate conditions characterized by hypo- as well as hypercoagulability and as a laboratory tool to elucidate coagulation mechanisms that are not yet completely understood. This article aims to overview the value and limits of current procedures for TGA for the investigation of hemostasis.Keywords
Funding Information
- Italian Ministry of Health Ricerca Corrente (2023)
This publication has 51 references indexed in Scilit:
- ST Genesia reference values of 117 healthy donors measured with STG‐BleedScreen, STG‐DrugScreen and STG‐ThromboScreen reagentsResearch and Practice in Thrombosis and Haemostasis, 2020
- Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2020
- Body mass index reduction improves the baseline procoagulant imbalance of obese subjectsJournal of Thrombosis and Thrombolysis, 2019
- Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factorsEndocrine, 2016
- Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assayJournal of Thrombosis and Thrombolysis, 2010
- Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trialHepatology, 2008
- Thrombin generation in patients with cirrhosis: The role of plateletsHepatology, 2006
- Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacityHepatology, 2006
- Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver diseaseLiver Transplantation, 2005
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡Hepatology, 2005